26-a-11239-Acc Efficacy of Sotagliflozin for Heart Failure and Major Adverse Cardiovascular Events by Body Mass Index: A Prespecified Analysis of Scored | Synapse
March 31, 2026
26-a-11239-Acc Efficacy of Sotagliflozin for Heart Failure and Major Adverse Cardiovascular Events by Body Mass Index: A Prespecified Analysis of Scored
Key Points
Key points are not available for this paper at this time.